Business

Announcement on Lifting Sales Restrictions and Listing in the 1st Lifting Period under the 2024 Restricted Stock Incentive Plan

Announcement on Lifting Sales Restrictions and Listing in the 1st Lifting Period under the 2024 Restricted Stock Incentive Plan

articleZhejiang East Asia Pharmaceutical Co., Ltd. Class AApril 27, 20263/news/announcement-on-lifting-sales-restrictions-and-listing-in-the-1st-lifting-period-under-the-2024-restricted-stock-incentive-plan-1
Announcement on Lifting Sales Restrictions and Listing in the 1st Lifting Period under the 2024 Restricted Stock Incentive Plan

About this update from Zhejiang East Asia Pharmaceutical Co., Ltd. Class A

Announcement on Lifting Sales Restrictions and Listing in the 1st Lifting Period under the 2024 Restricted Stock Incentive Plan The total number of shares to be listed and circulated this time is 1,068,052 shares; the listing and circulation date is May 6, 2026.The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:View Attachment

View stock analysis, news, and events for Zhejiang East Asia Pharmaceutical Co., Ltd. Class A